Dr. Michael Mersol-Barg is the Medical and Laboratory Director of Michigan
Reproductive Medicine. He is also an Associate Professor of Obstetrics &
Gynecology at Oakland University William Beaumont School of Medicine and at
Wayne State University School of Medicine.
He has been a high complexity laboratory director for over 25 years. Dr. Mersol-
Barg has served as an inspector for the College of American Pathologists’
Reproductive Laboratory Accreditation program, where he visited IVF labs
around the country to evaluate and advise them.
Dr. Mersol-Barg is a 2015-2017 Clinical Research/Reproductive Scientist
Training (CREST) Scholar which is a joint training program awarded by the
National Institute of Child Health and Human Development (NICHD), the Clinical
Research Training Program (CRTP) at Duke University, and the American
Society for Reproductive Medicine (ASRM). This is a highly competitive program
where only a few physicians throughout the country are chosen to participate.
After graduating from The Ohio State University College of Medicine, Dr. Mersol-
Barg completed his internship and residency training in OB/GYN at Johns
Hopkins Hospital in Baltimore, MD. He then continued his fellowship training in
reproductive endocrinology & infertility at The Ohio State University. He received
the Berlex Research Foundation Faculty Development Award, which started his
interest and focus on evidence-based medicine. Dr. Mersol-Barg is board
certified in obstetrics & gynecology and in the subspecialty of reproductive
endocrinology & infertility. Dr. Mersol-Barg is on staff at Beaumont Health-Royal
Oak and Troy, Detroit Medical Center and St. Joseph Mercy Oakland.
An experienced and respected fertility doctor and scientist, Dr. Mersol-Barg has
published peer reviewed papers and ongoing research in the areas of hormone
therapy, IVF, egg freezing and pelvic surgery.
He has presented research findings and scientific data at both national and
international meetings. He serves as a reviewer for peer review journals such as
Fertility & Sterility and The Journal of Minimally Invasive Gynecology, currently
serving on their editorial board.
Dr. Mersol-Barg shows his commitment to serving the Michigan community as
president of the Michigan Society for Reproductive Endocrinology and Infertility
since 2002, and as president of the Michigan Oncofertility Society, which Dr.
Mersol-Barg founded in 2012 to educate doctors and patients on cancer and
fertility preservation here in Michigan. Our practice, Michigan Reproductive
Medicine, is a nationally recognized Oncofertility Center of Excellence and a
member of its Physician National Cooperative Network.
Dr. Mersol-Barg is the physician representative for Michigan in the national
SMART (States Monitoring Assisted Reproductive Technology) Collaborative,
which actively works with the Michigan Department of Health and Human
Services and the Centers for Disease Control and Prevention (CDC) towards
studying the health outcomes of mothers and babies born by means of assisted
reproductive technologies, such as IVF. Linking treatments to results will help
fertility doctors improve and optimize their care for men and women needing
therapy. Dr. Mersol-Barg is a co-author on studies published and ongoing
through the SMART Collaborative. He was elected in 2010 as the current Chair
of the State of Michigan’s Fertility Advisory Committee, which works with
Michigan’s Department of Health and Human Services.
Dr. Mersol-Barg’s peers have voted for him as one of Hour Magazine’s “Top
Docs” for many years, including the current award for 2022-2023. A large number
of physicians have further honored him by choosing Dr. Mersol-Barg for their
medical care. A national independent group named Dr. Mersol-Barg a “Super
Doctor”, the Expert Network recently named him a “Distinguished Doctor” for
being in the top 3% of physicians in the United States, and US News and World
Report recognizes Dr. Mersol-Barg as a “Top Doctor”.